Henderson L W
Kidney Int. 1986 Apr;29(4):901-7. doi: 10.1038/ki.1986.84.
Twenty-one stable maintenance hemodialysis patients were studied in a crossover format with hemofiltration to determine whether the lower incidence of symptomatic hypotension noted with hemofiltration could be correlated with changes in baroreflex function as tested using the cold pressor test and amyl nitrite inhalation study. Baroreflex function remained abnormal and unchanged in all patients in the face of a reduced incidence of symptomatic hypotension. Subdivision of the patients into frequent (greater than 1 episode/treatment) and infrequent (less than 1 episode/treatment) reactors during the hemodialysis control period resulted in the infrequent reactors, showing a significant increase in episodes of symptomatic hypotension/hemofiltration treatment where a significant reduction was noted with the frequent reactors. No clear correlation could be made between the incidence of symptomatic hypotension and the pre- to post-treatment change in body temperature. The presence of pretreatment hypertension, another previously identified correlate of symptomatic hypotension with hemodialysis, also could not be corroborated. Further, changes from baseline predialysis values in mean arterial pressure noted with hemofiltration could not be correlated with a changed incidence of symptomatic hypotension. We conclude that previously identified correlates of symptomatic hypotension noted in the hemodialysis setting may be dissociated during treatment with hemofiltration and that there is a heterogeneous patient response to this treatment. These data suggest that there are additional, as yet undetermined, pathophysiologic events that underly the symptomatic hypotension of artificial kidney treatment.
对21名维持性稳定血液透析患者采用交叉方式进行血液滤过研究,以确定血液滤过所致症状性低血压发生率较低是否与压力反射功能变化相关,压力反射功能通过冷加压试验和亚硝酸异戊酯吸入试验进行检测。尽管症状性低血压发生率降低,但所有患者的压力反射功能仍保持异常且无变化。在血液透析对照期,将患者分为频繁(每次治疗发作次数>1次)和不频繁(每次治疗发作次数<1次)反应者,结果显示不频繁反应者在血液滤过治疗时症状性低血压发作次数显著增加,而频繁反应者则显著减少。症状性低血压发生率与治疗前后体温变化之间无明显相关性。先前确定的血液透析症状性低血压的另一个相关因素——治疗前高血压的存在,也未得到证实。此外,血液滤过导致的平均动脉压相对于透析前基线值的变化与症状性低血压发生率的改变无关。我们得出结论,在血液透析环境中先前确定的症状性低血压相关因素在血液滤过治疗期间可能会分离,并且患者对这种治疗的反应存在异质性。这些数据表明,在人工肾治疗的症状性低血压背后,存在其他尚未确定的病理生理事件。